Friday, April 18, 2014 11:50:01 AM
-NWBO submitted an abstract for the DCVax Direct trial with data collected up to as late as February. It is, by definition, not a LBA, nor a TIP abstract.
-Their abstract title only will be available next week (Apr 21). Just the title. That might give us some clues as to what will be in the abstract and thus meeting (ASCO).
-The full abstract will go public May 14th. This will give us some clues as to what's in the full study report (undisclosed until ASCO). It will in format be similar to most study abstracts.
-The full study data, including any results tabulated up until May 19th, will be fully disclosed during one of two sessions at ASCO itself, on May 30th. I am of the opinion it will be during the oral sessions. Vivek Subbiah will conduct the talk. Incidentally, this is the same day the LBAs become disclosed, and will continue to over the following days (not relevant to NWBO).
-At the same time or immediately following that session in which data accumulated in the Direct trial up until 5/19 is divulged, a public release will occur in which we are all notified of the same. And I am expecting those results to show significant effect, especially in regards to tumor necrosis, and possibly evidence of systemic response (less likely at this early stage, imo).
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM